Eli Lilly and Company

Eli Lilly and Company

Press Release: AbbVie, Eli Lilly exit UK drug pricing agreement Jan 16 (Reuters) - Pharmaceutical companies AbbVie and Eli Lilly have withdrawn from Britain's voluntary medicines pricing agreement, an industry b...

Impact on the Pharmaceutical Industry

AbbVie and Eli Lilly's decision to exit the UK drug pricing agreement is expected to have significant implications for the pharmaceutical industry. This move could potentially lead to changes in drug pricing strategies and regulations, impacting both companies and consumers.

About Eli Lilly

Eli Lilly and Company is a global healthcare leader that focuses on creating innovative solutions to address unmet medical needs. With a long history of developing breakthrough treatments, Eli Lilly remains committed to improving the lives of patients worldwide.